Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development

Drug Discovery & Development

Ethypharm agrees to acquire UK-based Martindale Pharma Ethypharm has agreed to acquire Martindale Pharma, a UK-based specialty pharmaceutical firm offering essential medicines to more than 50 countries across the world.
Drug Research > Drug Discovery & Development > News
Takeda, Ovid to co-develop rare pediatric epilepsy candidate TAK-935 Takeda Pharmaceutical said its rare pediatric epilepsy candidate TAK-935 will be co-developed through a partnership with Ovid Therapeutics.
Drug Research > Drug Discovery & Development > News Horizon Discovery broadens gene editing capabilities Horizon Discovery Group has expanded its gene editing capabilities through the amendment of a pre-existing license with ERS Genomics to include the full commercial rights for the use of CRISPR edited cell lines for the Good Manufacturing Practice (GMP) manufacturing of biotherapeutics.
Drug Research > Drug Discovery & Development > News
See more Drug Discovery & Development news

Latest Drug Discovery & Development News and Insight

View all Drug Discovery & Development news or find news targeted to your interests
Malin buys 33% interest in UK's Wren Therapeutics
By PBR Staff Writer
Irish life sciences firm Malin has acquired a 33% stake in UK biopharmaceutical company, Wren Therapeutics.
Drug Research > Drug Discovery & Development > News
Aptevo Therapeutics receives $20m payment from Emergent BioSolutions
Aptevo Therapeutics has received a $20m cash payment from Emergent BioSolutions pursuant to a promissory note granted as a result of the spin-off of Aptevo from Emergent, effective August 1, 2016.
Drug Research > Drug Discovery & Development > News
Nivalis Therapeutics unveils corporate restructuring
Nivalis Therapeutics, a clinical stage pharmaceutical firm engaged in the development of new solutions for people with cystic fibrosis (CF), announced that its board of directors has approved a restructuring plan as part of its initiative to evaluate strategic alternatives focused on maximizing stockholder value from its clinical assets and cash resources.
Drug Research > Drug Discovery & Development > News
Clinical-stage biopharmaceutical firm OncoImmune raises $15m funding
OncoImmune, a privately-held, clinical-stage biopharmaceutical company that is actively engaged in the discovery and development of novel immunotherapies for cancer, inflammation and autoimmune diseases, has secured $15m in Series A round of fundraising led by 3E Bioventures Capital.
Drug Research > Drug Discovery & Development > News
Merck expands oncology portfolio with four Vertex cancer programs
By PBR Staff Writer
Merck has agreed to license four oncology research and development (R&D) programs from Vertex Pharmaceuticals.
Drug Research > Drug Discovery & Development > News
Zebra Biologics to partner with AbbVie on new antibody therapeutics discovery
Pre-clinical stage biotechnology firm Zebra Biologics has partnered with AbbVie to discover agonist antibody therapeutics for inflammatory diseases.
Drug Research > Drug Discovery & Development > News
Silence Therapeutics acquires minority stake in Arrowhead Pharmaceuticals
Silence Therapeutics has made a $9.6m equity investment in Arrowhead Pharmaceuticals.
Drug Research > Drug Discovery & Development > News
View all Drug Discovery & Development news or find news targeted to your interests